Vol. 3 No. 1 (2026)

View Vol. 3 No. 1 (2026)

Published: 2026-08-18

Editorial

First-Line Lung Cancer Combinations: Are We Treating Better, or Simply Adding Drugs?

Telma Sequeira

4 - 5
- PDF

Original Article

Real-World Treatment Pathways in Stage III Non-Small-Cell Lung Cancer Surgical Patients in Portugal

Encarnação Teixeira, Gabriela O. Fernandes, Lurdes Ferreira, Fernanda Estevinho, José Albino Lopes, António Araújo, Maria Manuel Figueiredo, Lourdes Barradas, Miguel Lopes, Ulisses Brito, Carolina Camacho, Bárbara Parente, Margarida Felizardo, António Meleiro, Manuela Bernardo, Carolina Antunes, Filipa Bernardo, Sara Figueiredo

6 - 24
- PDF
Comparison of Receptor Profiles Between Primary Tumors and Isolated Thoracic Metastasesin Breast Cancer

Aybiyçe Elif Silpağar Güner, Eyüp Halit Yardımcı, Mehmet Yıldırım

26 - 34
- PDF

Case Report

Triple-Dose Furmonertinib for Leptomeningeal Metastases in Advanced EGFR L858R-Mutated Lung Adenocarcinoma: A Case Report

Hong Wu, Lei Li, Jing Yang, Yuan Tian, Hui Wang

36 - 41
- PDF
Testicular Metastasis as a Sanctuary Site Detected on 18F-FDG PET-CT in Disseminated Small-Cell Lung Cancer: A Diagnostic and Management Dilemma

Alok Mandal, Preeti Sharma, Parneet Singh, Sachet Saxena

42 - 45
- PDF
Lung Cancer and Immunotherapy: When the Immune System Becomes the New Challenge

Rciardo Petinga Fortes, Inês Sucena Pereira, Daniela Cardoso, Jorge Dionísio

46 - 52
- PDF